Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

ImmuPharma PLC (IMM)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
7.16 -0.20    -2.72%
20/10 - Closed. Currency in GBP ( Disclaimer )
  • Volume: 439,787
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 7.16 - 7.40
Type:  Equity
Market:  United Kingdom
ISIN:  GB0033711010 
SEDOL:  3371101
ImmuPharma 7.16 -0.20 -2.72%

IMM News

 
This page features the latest ImmuPharma PLC share news. Assess the latest information about the ImmuPharma PLC stock.
ImmuPharma bids farewell to CEO in boardroom re-shuffle
ImmuPharma bids farewell to CEO in boardroom re-shuffle
By Proactiveinvestors - Jul 30, 2021

Drug developer ImmuPharma PLC (LON:IMM; Euronext Growth Brussels:ALIMM) has announced a number of boardroom changes including the departure of its long-serving chief executive to “pursue a number of...

ImmuPharma appoints chief operating officer to the board
ImmuPharma appoints chief operating officer to the board
By Proactiveinvestors - Jul 16, 2021

ImmuPharma PLC (LON:IMM) has appointed its chief operating officer, Dr Tim Franklin, to the board. He has been with the drug developer for three years, starting as a consultant, and was appointed COO...

ImmuPharma pushes ahead with drug research efforts
ImmuPharma pushes ahead with drug research efforts
By Proactiveinvestors - Jun 24, 2021

This makes it a perfect fit for Lupuzor Boss Dimitri Dimitriou said of the company's deal with Avion Pharmaceuticals What it does ImmuPharma PLC (LON:IMM) is the developer of Lupuzor, a treatment for...

ImmuPharma partner makes headway with US FDA
ImmuPharma partner makes headway with US FDA
By Proactiveinvestors - Jun 24, 2021

ImmuPharma PLC (LON:IMM, Euronext Growth Brussels:ALIMM) said its US partner has received a positive response from the American drug regulator ahead of a pharmacokinetic (PK) assessment of its lupus...

 
Next
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

IMM Comments

Write your thoughts about ImmuPharma PLC
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ken Laing
Ken Laing Sep 15, 2021 9:52
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Added some more at this crazy price, its now my biggest holding in the portfolio.
Reply
1 0
Report
Ken Laing
Ken Laing Mar 28, 2021 18:04
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
“The strengthened balance sheet position following the £6.5m placing in September 2020, provides a cash runway to end 2023. Lupus being an attractive market and poorly met medical need, Dr Malik believes the shares are oversold and reiterate their BUY rating and TP of 100p.”
Reply
2 1
Report
Jonny Tr
Jonny Tr Mar 28, 2021 18:04
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
dr malik joking right? tp 100p give the company a market cap of 250M! tell me would u buy a company for 250m with 10m on the balance sheet?
Reply
0 1
Report
Ken Laing
Ken Laing Mar 28, 2021 14:11
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This report is worth readinghttps://thelifesciencesdivision.com/research/portal/?#/portal/the-life-sciences-division/research/c84d1aa9-f672-42fb-a774-ab7fe84a3a99/referrer/GB0033711010
Reply
0 1
Report
Ken Laing
Ken Laing Mar 20, 2021 20:54
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Looks like this has finally bottomed. I have built a substantial size position and expect to see it be 20p at least in a few months
Reply
2 0
Report
Chanie Taggart
Chanie Taggart Mar 18, 2021 12:25
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I had this at 9.16 unfortunately.
Reply
0 0
Report
salim hudda
salim hudda Mar 09, 2021 14:59
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
its a time to load up ,in the stochastic over sold zone,just needs a bit of volume ,will move up very quickly
Reply
1 0
Report
Ken Laing
Ken Laing Feb 09, 2021 11:09
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Now its the time to buy. RNS looks neutural, just slight delay
Reply
2 0
Report
Ken Laing
Ken Laing Jan 04, 2021 12:42
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
One of the top shareholders sold a big chunk on the last day of 2020....not a good sign
Reply
1 0
Report
Ken Laing
Ken Laing Dec 15, 2020 9:42
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This share is dead
Reply
4 0
Report
bharat modhwadia
bharat modhwadia Nov 19, 2020 13:34
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
this gone more then double soon as the new drugs approved
Reply
2 1
Report
Ken Laing
Ken Laing Jun 25, 2020 18:17
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Bargain of the year, the potential for this is huge. Easily 100% gain before xmas
Reply
2 0
Report
Muhammed Asif Khan
Muhammed Asif Khan Jun 25, 2020 18:17
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
can see investers are lining up
Reply
0 0
Report
Sam Charlesworth
Sam Charlesworth Dec 20, 2019 15:44
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
shorts are closing, this is going to rally back now
Reply
1 1
Report
Naveed Tariq
Naveed Tariq Dec 11, 2019 11:23
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
time to buy
Reply
2 1
Report
Muhammed Asif Khan
Muhammed Asif Khan Jun 07, 2019 16:27
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
this share is doing taxi.....nearly taking off....good time to buy....fill the boots to avoid buying expensive.......
Reply
0 0
Report
Scary Cary
Scary Cary Nov 19, 2018 16:24
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Lets hope so
Reply
0 2
Report
Scary Cary
Scary Cary Nov 19, 2018 16:24
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I’d be happy with £5
Reply
3 2
Report
Adeel Khan
Adeel Khan Apr 03, 2018 18:04
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
It’s now or never. I believe this will be £5 by next week.
Reply
1 3
Report
Ferrero Rocher
Ferrero Rocher Apr 03, 2018 18:04
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Fluffed it.  Theres been a nasty drop today.
Reply
1 0
Report
Luke Hobson
Luke Hobson Apr 03, 2018 18:04
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Lol
Reply
0 0
Report
Adeel Khan
Adeel Khan Jan 08, 2018 8:45
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Lincese deal coming up soon. £5 on the cards
Reply
0 3
Report
Adeel Khan
Adeel Khan Sep 26, 2017 9:47
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Share price to increase by 100%.
Reply
0 1
Report
Franco Russo
Franco Russo Sep 26, 2017 9:47
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Support your view with some facts / analysis
Reply
1 0
Report
Adeel Khan
Adeel Khan Sep 26, 2017 9:47
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
It did and you missed the boat.
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email